| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | 0.0064 | 0.9 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.9 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.0087 | 0.9 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | -0.0064 | 0.9 |
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | 0.006 | 0.9 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | 0.006 | 0.9 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | -0.0085 | 0.9 |
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | 0.0053 | 0.9 |
| mRNA | JQ12 | GDSC1000 | pan-cancer | AAC | -0.0057 | 0.9 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | -0.0062 | 0.9 |